Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rivastigmin and impaired motor function.

M Heinze1, D Andreae, R Grohmann

  • 1Department of Psychiatry and Psychotherapy, Landesklinik Teupitz, Teupitz, Germany. heinzem@zedat.fu-berlin.de

Pharmacopsychiatry
|April 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging the knowledge gap: a mixed-methods study on general practitioners' information needs for mHealth apps in hypertension treatment in Germany.

BMC health services research·2025
Same author

A comparative study of multi and single post labeling delay pseudocontinuous arterial spin labeling in patients with carotid artery stenosis.

Magnetic resonance imaging·2023
Same author

Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016.

Journal of neural transmission (Vienna, Austria : 1996)·2023
Same author

Correction to: Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia.

The Psychiatric quarterly·2022
Same author

Incidence of Drug-Induced Delirium During Treatment With Antidepressants or Antipsychotics: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2016.

The international journal of neuropsychopharmacology·2022
Same author

[Expectations of patients and relatives for modern hospital care in geriatric psychiatry].

Zeitschrift fur Gerontologie und Geriatrie·2021

This case study details severe motor dysfunction in an Alzheimer's patient treated with rivastigmine. This adverse effect highlights potential risks associated with cholinesterase inhibitors.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Geriatrics

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
  • Cholinesterase inhibitors are a common treatment for Alzheimer's disease.
  • Rivastigmine is a centrally acting cholinesterase inhibitor used to treat dementia associated with Alzheimer's disease and Parkinson's disease.

Observation:

  • An 88-year-old female patient with Alzheimer's disease was treated with rivastigmine.
  • The patient developed severe motor dysfunction during rivastigmine treatment.

Findings:

  • The observed motor dysfunction is a potential adverse effect of rivastigmine.
  • This case adds to existing reports of motor impairments linked to cholinesterase inhibitors.

Related Experiment Videos

Implications:

  • Clinicians should be vigilant for motor side effects in Alzheimer's patients on rivastigmine.
  • Further research may be needed to understand the mechanisms behind cholinesterase inhibitor-induced motor dysfunction.
  • This finding may influence treatment strategies for Alzheimer's disease.